Edit Tarcsa

Edit Tarcsa

Company: AbbVie

Job title: DMPK-BA Site Head East Coast


Research Fellow
QTAS Site Head, AbbVie Bioresearch Center, Worcester, MA
Responsible for developing bioanalytical strategy for biologics and novel therapeutic modalities including gene and cell therapy. Currently focused on developability and immunogenicity risk assessment strategies. Prior to Abbvie, completed a Postdoctoral fellowship in cell biology at Harvard Medical School, an NIH fellowship at NIAMS, Bethesda, and received a PhD in biochemistry from the University Medical School of Debrecen, Hungary


Hope for the Best but Prepare for the Worst: Considerations for Gene Therapy Treatment in Populations with Pre-existing Anti-AAV Antibodies 3:45 pm

Anti AAV antibody assays or CDx; Context of use: pre-existing versus treatment induced anti-AAV antibodies Benefit risk assessment based on medical need and route of administration Benefit risk assessment based on pre-existing antibodies Patient exclusion or plan to overcome pre-existing immunityRead more

day: Day 1 PM

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.